New β-lactamase inhibitors: A therapeutic renaissance in an MDR world

Keyphrases

• Multidrug-resistant 100%
• Renaissance 100%
• β-lactamase Inhibitor 100%
• Avibactam 40%
• Clinical Trials 20%
• Therapeutic Approaches 20%
• Dosing Regimen 20%
• Effective Treatment 20%
• Clinical Application 20%
• Multidrug-resistant Gram-negative Bacteria 20%
• Preclinical Development 20%
• Lactams 20%
• Recent Advances 20%
• Gram-negative Bacterial Infections 20%
• Novel Mechanism of Action 20%
• β-lactamase 20%
• Clinical Problems 20%
• Diazabicyclooctane 20%
• Boronates 20%
• Select Agent 20%
• MK-7655 20%
• NewHope 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Penicillinase 100%
• Avibactam 33%
• Clinical Trial 16%
• Lactam 16%
• Select Agent 16%
• Multidrug-Resistant Gram-Negative Bacteria 16%
• Gram Negative Infection 16%
• Vaborbactam 16%